HLG Genomics Plunges 31% on Debut Day; 82% of Recent IPOs Trading Below Issue Price

HLG Genomics, which listed on KOSDAQ on Thursday (July 24), fell 31% on its debut day. The company raised over 4 trillion Korean won in subscription deposits during its IPO, though institutional investors showed limited commitment to long-term holding. According to market data, 82% of companies that went public in the past three months are currently trading below their offer prices.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments